Investor insights
Countries invested in
Sectors invested in
Funding rounds participated in
$28M sweet spot round size
Most of their 87 investments are in rounds between $8M and $57M
Investor type
Basic info
Industry
Sectors
Date founded
2004
Investments made
Adcendo raised $34M on April 4, 2023
Investors: Gilde Healthcare, HealthCap, Ysios Capital, RA Capital Management, L.P., Novo Holdings and Pontifax Venture Capital
Amolyt Pharma raised $137M on January 6, 2023
Investors: Tekla Capital Management, Intermediate Capital Group (ICG), OrbiMed Advisors, Sofinnova Partners, Sectoral Asset Management and Pontifax Venture Capital
Precirix raised $88M on March 16, 2022
Investors: Gimv, Inkef, HealthCap, Novo Holdings, V-Bio Ventures, BioMedPartners, Forbion and Pontifax Venture Capital
Undisclosed raised $35M on December 20, 2021
Investors: Forbion and Pontifax Venture Capital
ANAVEON AG raised $119M on December 16, 2021
Investors: Syncona Limited, Forbion and Pontifax Venture Capital
V-Wave raised $98M on December 16, 2021
Investors: Triventures, Pura Vida Investments, Aperture Venture Partners, BRM Group, Quark Venture, ISF Israel Secondary Fund, Endeavour Vision and Pontifax Venture Capital
Emergence Therapeutics raised $98M on December 7, 2021
Investors: Hadean Ventures, OrbiMed Advisors, Surveyor Capital, RA Capital Management, L.P., NRW.BANK, High-Tech Gründerfonds, Gründerfonds Ruhr and Pontifax Venture Capital
Antios Therapeutics raised $75M on November 3, 2021
Investors: GRA Venture Fund LLC, Sixty Degree Capital, GordonMD Global Investments LP, RA Capital Management, L.P., LifeSci Venture Partners, Lumira Ventures, Soleus Capital Management, L.P. and Pontifax Venture Capital
Amolyt Pharma raised $80M on September 16, 2021
Investors: OrbiMed Advisors, Sectoral Asset Management, SHAM, Eurazeo, EQT Life Sciences and Pontifax Venture Capital
Theseus Pharmaceuticals raised $100M on April 13, 2021
Investors: Omega Funds, Nextech Invest, T. Rowe Price, Farallon Capital Management, OrbiMed Advisors, Foresite Capital, Longitude Capital and Pontifax Venture Capital